Medindia

X

Drug to Treat Parkinsonís Disease Launched in the US Market by Dr Reddy's Laboratories

by Lakshmi Darshini on  August 13, 2015 at 6:07 PM Drug News   - G J E 4
Generic Pramipexole dihydrochloride extended-release tablets for treatment of Parkinson's disease has been launched by Dr Reddy's Laboratories in the US market.
Drug to Treat Parkinsonís Disease Launched in the US Market by Dr Reddy's Laboratories
Drug to Treat Parkinsonís Disease Launched in the US Market by Dr Reddy's Laboratories
Advertisement

It has launched the tablets in the strengths of 0.375 mg, 0.75 mg, 1.5 mg, 3 mg and 4.5 mg in the US market following approval from the US Food & Drug Administration (USFDA), said Dr Reddy's Laboratories.

Advertisement
The company's product is generic version of Mirapex ER tablets. "The Mirapex ER brand and generic had US sales of approximately USD 48.3 million MAT for the most recent twelve months ending in June 2015 according to IMS Health," it said.

The DRL product is available in bottle count sizes of 30, it added.

Source: PTI
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All